Valuation : genedrive plc

Market Cap 20.87M 28.24M 24.28M 22.91M 39.02M 2.7B 39.37M 273M 105M 1.37B 106M 104M 4.35B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.64M 22.91M 21.61M 36.81M 2.55B 37.14M 257M 99.07M 1.29B 100M 97.84M 4.1B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.41%
Yield 2024 *
-
Yield 2025 -
1 day+3.84%
1 week-1.83%
Current month-3.58%
1 month+12.49%
3 months+14.89%
6 months+27.95%
Current year+54.27%
1 week 1.25
Extreme 1.25
1.45
1 month 1.15
Extreme 1.15
1.55
Current year 0.75
Extreme 0.75
1.55
1 year 0.19
Extreme 0.19
1.55
3 years 0.19
Extreme 0.19
13.5
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Chairman 80 13/07/2026
Director/Board Member 52 22/08/2018
Director/Board Member 69 09/04/2018
Date Insider Type Main position Quantity % Market Cap. Importance
20/12/24 Buy

Chief Financial Officer

1,000,000 0.1841%
20/12/24 Free 400,000 0.0736%
20/12/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
+3.84%-1.83%+115.98%-89.18% 28.24M
+0.54%-2.02%+20.04%-31.20% 16.65B
+4.40%+8.97%-30.26%+60.96% 1.78B
+0.69%-3.66%-27.64%+23.64% 894M
-3.88%-12.78%-56.03%-83.72% 833M
-0.16%-0.27%+68.52%-3.25% 778M
-1.89%-2.59%-35.58%-48.27% 654M
-2.22%-4.26%-41.91%-46.05% 591M
+3.26%-14.92%-43.23%-39.69% 436M
-3.51%-6.87%+64.04%+45.87% 386M
Average +0.11%-5.36%+3.39%-21.09% 2.3B
Weighted average by Cap. +0.51%-4.84%+9.68%-22.70%

Financials

2024 2025
Net sales 501K 678K 583K 550K 937K 64.8M 945K 6.55M 2.52M 32.87M 2.55M 2.49M 104M 954K 1.29M 1.11M 1.05M 1.78M 123M 1.8M 12.47M 4.8M 62.58M 4.85M 4.74M 199M
Net income -7.08M -9.57M -8.23M -7.77M -13.23M -915M -13.35M -92.49M -35.6M -464M -35.94M -35.16M -1.47B -5.23M -7.08M -6.09M -5.74M -9.78M -677M -9.87M -68.39M -26.32M -343M -26.57M -25.99M -1.09B
Net Debt -5.17M -6.99M -6.01M -5.67M -9.66M -669M -9.75M -67.58M -26.01M -339M -26.26M -25.68M -1.08B -1.18M -1.6M -1.38M -1.3M -2.21M -153M -2.23M -15.45M -5.95M -77.54M -6M -5.87M -246M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
11/09/26 GBX 1.350 +3.84% 299,303
10/09/26 GBX 1.300 -1.89% 1,067,251
09/09/26 GBX 1.325 +1.92% 6,346,424
08/09/26 GBX 1.300 -3.70% 3,653,041
07/09/26 GBX 1.350 -1.82% 3,136,892

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!